Related references
Note: Only part of the references are listed.Pharmacokinetics and Tolerability of Rizatriptan in Pediatric Migraineurs in a Randomized Study
Iain P. Fraser et al.
HEADACHE (2012)
Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies
Ishaq Abu-Arafeh et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2010)
Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies
S. Evers et al.
CEPHALALGIA (2009)
Efficacy and tolerability of almotriptan in adolescents: A randomized, double-blind, placebo-controlled trial
Steven L. Linder et al.
HEADACHE (2008)
The placebo response in studies of acute migraine
Ricardo Fernandes et al.
JOURNAL OF PEDIATRICS (2008)
Migraine prevalence, disease burden, and the need for preventive therapy
R. B. Lipton et al.
NEUROLOGY (2007)
A randomized trial of rizatriptan in migraine attacks in children
K. Ahonen et al.
NEUROLOGY (2006)
Sumatriptan nasal spray in adolescent migraineurs: A randomized, double-blind, placebo-controlled, acute study
P Winner et al.
HEADACHE (2006)
Pharmacokinetic profile of rizatriptan 10-mg tablet and 10-mg orally disintegrating tablet administered with or without water in healthy subjects: An open-label, randomized, single-dose, 3-period crossover study
SK Swan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Practice parameter: Pharmacological treatment of migraine headache in children and adolescents. Report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society
DW Lewis et al.
HEADACHE (2005)
Practice parameter: Pharmacological treatment of migraine headache in children and adolescents - Report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society
D Lewis et al.
NEUROLOGY (2004)
Children's ibuprofen suspension for the acute treatment of pediatric migraine
DW Lewis et al.
HEADACHE (2002)
Practice parameter: Evaluation of children and adolescents with recurrent headaches - Report of the quality standards subcommittee of the American Academy of Neurology and the practice Committee of the Child Neurology Society
DW Lewis et al.
NEUROLOGY (2002)
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: A randomized, double-blind, placebo-controlled study
P Winner et al.
HEADACHE (2002)
Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials
MD Ferrari et al.
CEPHALALGIA (2001)
Share Paper
